ECRIN has contributed to a publication entitled “Publicly funded practice-oriented clinical trials: of importance for healthcare payers”.
The authors considered whether or not there are benefits to governments in funding practice-oriented clinical trials. For this purpose, they assessed publications from institutional websites, as well as information gathered from (inter)national stakeholders. Areas were identified where public funding of clinical trials is of importance for society.
The findings of the literature review suggest that publicly-funded research programmes could provide a positive return on investment, while providing insight into the main hurdles and success factors for the successful conduct of publicly-funded trials.
The authors conclude that governments should see public funding of pragmatic practice-oriented clinical trials as a good opportunity to improve the selection and quality of treatments and stimulate the efficient use of limited resources.